| 1 |
Antimisiaris SG. Preparation of DRV Liposomes. Methods Mol Biol 2023;2622:21-47. [PMID: 36781747 DOI: 10.1007/978-1-0716-2954-3_2] [Reference Citation Analysis]
|
| 2 |
Abdella S, Abid F, Youssef SH, Kim S, Afinjuomo F, Malinga C, Song Y, Garg S. pH and its applications in targeted drug delivery. Drug Discov Today 2023;28:103414. [PMID: 36273779 DOI: 10.1016/j.drudis.2022.103414] [Reference Citation Analysis]
|
| 3 |
Lopes J, Rodrigues CMP, Gaspar MM, Reis CP. Melanoma Management: From Epidemiology to Treatment and Latest Advances. Cancers 2022;14:4652. [DOI: 10.3390/cancers14194652] [Reference Citation Analysis]
|
| 4 |
Lopes J, Rodrigues CMP, Gaspar MM, Reis CP. How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT. Pharmaceutics 2022;14:1817. [DOI: 10.3390/pharmaceutics14091817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Ezealigo BN, Ezealigo US, Ighodalo KI, Ezema FI. Iron oxide nanoparticles: current and future applications in nanomedicine. Fundamentals and Industrial Applications of Magnetic Nanoparticles 2022. [DOI: 10.1016/b978-0-12-822819-7.00011-9] [Reference Citation Analysis]
|
| 6 |
Shevtsov M, Kaesler S, Posch C, Multhoff G, Biedermann T. Magnetic nanoparticles in theranostics of malignant melanoma. EJNMMI Res 2021;11:127. [PMID: 34905138 DOI: 10.1186/s13550-021-00868-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Matias M, Pinho JO, Penetra MJ, Campos G, Reis CP, Gaspar MM. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval. Cells 2021;10:3088. [PMID: 34831311 DOI: 10.3390/cells10113088] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Mîndrilă I, Osman A, Mîndrilă B, Predoi MC, Mihaiescu DE, Buteică SA. Phenotypic Switching of B16F10 Melanoma Cells as a Stress Adaptation Response to Fe3O4/Salicylic Acid Nanoparticle Therapy. Pharmaceuticals (Basel) 2021;14:1007. [PMID: 34681232 DOI: 10.3390/ph14101007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Seaberg J, Montazerian H, Hossen MN, Bhattacharya R, Khademhosseini A, Mukherjee P. Hybrid Nanosystems for Biomedical Applications. ACS Nano 2021;15:2099-142. [PMID: 33497197 DOI: 10.1021/acsnano.0c09382] [Cited by in Crossref: 50] [Cited by in F6Publishing: 58] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 10 |
Predoi MC, Mîndrilă I, Buteică SA, Purcaru ȘO, Mihaiescu DE, Mărginean OM. Iron Oxide/Salicylic Acid Nanoparticles as Potential Therapy for B16F10 Melanoma Transplanted on the Chick Chorioallantoic Membrane. Processes 2020;8:706. [DOI: 10.3390/pr8060706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
